Gujarat Inject Kerala Ltd Reports Strong Q4 and Full-Year Results

Gujarat Inject Kerala Ltd has announced its financial results for the fourth quarter and the full fiscal year ended March 31, 2026. The company posted a standalone total income of ₹3,069.77 Lakh (₹30.70 Crores) for Q4 FY26, marking a significant 622.72% increase from ₹424.75 Lakh in the same quarter last year. Standalone net profit for the quarter reached ₹163.51 Lakh (₹1.64 Crores).

For the full fiscal year FY26, standalone total income grew by 89.93% to ₹3,651.67 Lakh (₹36.52 Crores), up from ₹1,922.62 Lakh in FY25. The annual standalone net profit showed a substantial improvement of 78.34%, rising from ₹101.72 Lakh in FY25 to ₹181.41 Lakh (₹1.81 Crores) in FY26.

Why These Results Matter

The strong Q4 performance significantly boosted the company's annual figures, reflecting substantial operational expansion. The nearly 80% year-on-year growth in annual net profit highlights improved profitability. The auditor's unmodified opinion further suggests that the financial statements are presented fairly, offering reassurance to investors.

Company Background

Gujarat Inject Kerala Ltd operates within the manufacturing sector. The considerable surge in income, particularly in the latest quarter, points to a significant scaling of its business activities or a successful ramp-up of new projects. The company's performance over the past year demonstrates a clear growth trajectory.

Investor Takeaways

Investors see a company that has achieved considerable growth in both its top-line revenue and bottom-line profit. The sharp increase in Q4 income, a major contributor to annual revenue, suggests a strong operational push. If sustained, this growth could lead to increased investor confidence.

Key Risks to Monitor

One notable concern is the drastic increase in trade payables, which rose from ₹167.05 Lakh to ₹2,024.56 Lakh in FY26. This indicates a significant increase in short-term obligations to suppliers, which could potentially strain working capital. Additionally, a high Capital Work-In-Progress (WIP) of ₹2,076.45 Lakh means substantial funds are tied up in ongoing projects that are not yet generating revenue, potentially impacting immediate cash flows.

Financial Metrics

• Q4 FY26 Standalone Total Income: ₹3,069.77 Lakh (up 622.72% YoY)
• Q4 FY26 Standalone Net Profit: ₹163.51 Lakh
• FY26 Standalone Total Income: ₹3,651.67 Lakh (up 89.93% YoY)
• FY26 Standalone Net Profit: ₹181.41 Lakh (up 78.34% YoY)
• FY26 Trade Payables: ₹2,024.56 Lakh (vs ₹167.05 Lakh in FY25)
• FY26 Capital Work-In-Progress: ₹2,076.45 Lakh

What to Watch Next

Investors should closely monitor the company's working capital management, particularly the trend in trade payables. They should also track the progress of capital work-in-progress projects to assess their return on investment. Continued revenue growth and profit generation will be key indicators going forward.